Clinical Trials Browser

Phase 2 × Breast Neoplasms × lenvatinib × Clear all

NCT05181033 2025-07-25

Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor

Phase 2 Recruiting

Breast Neoplasms

NCT03168074 2017-06-16

Phase II Study of Single Agent Lenvatinib

Phase 2 Unknown

Breast Neoplasms